Table 1.
Population and baseline characteristics.
| Baseline characteristics | Preventive medication group | Nonpreventive medication group | P-value |
|---|---|---|---|
| Numbers | 72 | 70 | |
| Age (years) | 61.43 ± 9.805 | 60.19 ± 8.742 | 0.426 |
| Sex (male/female) | 54/18 | 59/11 | 0.170 |
| Diabetes history (yes/no) | 9/63 | 4/66 | 0.161 |
| History of biliary surgery (yes/no) | 6/66 | 8/62 | 0.536 |
| Gallstone (yes/no) | 12/60 | 8/62 | 0.370 |
| Operation mode (c-tace/deb-tace) | 60/12 | 53/17 | 0.260 |
| Number of TACE (n) | 0.691 | ||
| First time | 33 | 29 | |
| Second time | 19 | 22 | |
| Third time | 10 | 6 | |
| Fourth time | 2 | 6 | |
| Fifth time | 4 | 3 | |
| Sixth time | 1 | 1 | |
| Seventh time | 1 | 1 | |
| Ninth time | 1 | 1 | |
| Tenth time | 1 | 0 | |
| Eleventh time | 0 | 1 | |
| Preoperative albumin value (g/L) | 34.654 ± 5.0938 | 34.817 ± 4.4169 | 0.839 |
| Preoperative leukocyte count (109/L) | 5.193 ± 2.2486 | 5.268 ± 1.8230 | 0.831 |